Federal contractor · SAN DIEGO, CA

VITAE ENIM VITAE SCIENTIFIC, INC.

VITAE ENIM VITAE SCIENTIFIC, INC. received $59.1K in federal contract obligations in FY2026, on 1 awards. Since FY2024: $382K. Its largest customer was National Institutes of Health ($59.1K).

Obligations · FY2026
$59.1K
New awards
1
Sole-source
0.0%
Single offer
0.0%
UEI
DXZ8K82VBBD5
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 322.9KFY2024
  2. 0FY2025
  3. 59.1KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$59.1K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$59.1K100%

Where the work was performed

  1. San Diego County, CA$59.1K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.7% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. DOSAGE FORM REPROCESS AND STABILITY STUDIES OF FX-5A INJECTION UNDER IDIQ CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES FOR DEVELOPMENT OF DRUG PRODUCTS$382K
    National Institutes of Health· San Diego County, CA· Research & development· Sep 27, 2024 – May 20, 2026· 75N95024F00002

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. QUVA PHARMA, INC.$376.3K
    SUGAR LAND, TX · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. UNITED BIOPHARMA, INC.$400K
    HSINCHU COUNTY, TWN · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. BIOLEGEND, INC.$373.6K−82% in FY2026
    SAN DIEGO, CA · 94% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.